LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)

Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Dasatinib
0.31623
12.17 27.76 36 489 0.0736 0.0648
MN20160318_Q01
L08
MCF 10A-H2B-mCherry Dasatinib
0.31623
12.17 27.76 1143 489 2.3371 1.4553
MN20160318_Q01
L08
MCF 10A-H2B-mCherry Dasatinib
0.31623
13.87 27.76 97 604 0.1604 0.3251
MN20160318_Q01
G09
MCF 10A-H2B-mCherry Dasatinib
0.31623
13.87 27.76 903 604 1.4933 1.1888
MN20160318_Q01
G09
MCF 10A-H2B-mCherry Dasatinib
0.31623
13.87 27.76 4 604 0.0066 -0.3533
MN20160318_Q01
H12
MCF 10A-H2B-mCherry Dasatinib
0.31623
13.87 27.76 969 604 1.6024 1.2238
MN20160318_Q01
H12
MCF 10A-H2B-mCherry Dasatinib
0.31623
13.87 27.76 391 604 0.6466 0.8131
MN20160318_Q01
L08
MCF 10A-H2B-mCherry Dasatinib
0.31623
13.87 27.76 1182 604 1.9546 1.3255
MN20160318_Q01
L08
MCF 10A-H2B-mCherry Dasatinib
0.31623
15.58 27.76 402 685 0.5864 0.7821
MN20160318_Q01
G09
MCF 10A-H2B-mCherry Dasatinib
0.31623
15.58 27.76 946 685 1.3799 1.1442
MN20160318_Q01
G09
MCF 10A-H2B-mCherry Dasatinib
0.31623
15.58 27.76 6 685 0.0088 -0.2819
MN20160318_Q01
H12
MCF 10A-H2B-mCherry Dasatinib
0.31623
15.58 27.76 988 685 1.4411 1.1644
MN20160318_Q01
H12
MCF 10A-H2B-mCherry Dasatinib
0.31623
15.58 27.76 612 685 0.8927 0.9515
MN20160318_Q01
L08
MCF 10A-H2B-mCherry Dasatinib
0.31623
15.58 27.76 1243 685 1.8131 1.2745
MN20160318_Q01
L08
MCF 10A-H2B-mCherry Dasatinib
0.31623
17.28 27.76 800 838 0.9538 0.9809
MN20160318_Q01
G09
MCF 10A-H2B-mCherry Dasatinib
0.31623
17.28 27.76 956 838 1.1398 1.0540
MN20160318_Q01
G09
MCF 10A-H2B-mCherry Dasatinib
0.31623
17.28 27.76 12 838 0.0143 -0.1568
MN20160318_Q01
H12
MCF 10A-H2B-mCherry Dasatinib
0.31623
17.28 27.76 1011 838 1.2054 1.0775
MN20160318_Q01
H12
MCF 10A-H2B-mCherry Dasatinib
0.31623
17.28 27.76 977 838 1.1649 1.0630
MN20160318_Q01
L08
MCF 10A-H2B-mCherry Dasatinib
0.31623
17.28 27.76 1268 838 1.5118 1.1754
MN20160318_Q01
L08
MCF 10A-H2B-mCherry Dasatinib
0.31623
18.98 27.76 875 941 0.9297 0.9715
MN20160318_Q01
G09
MCF 10A-H2B-mCherry Dasatinib
0.31623
18.98 27.76 981 941 1.0423 1.0164
MN20160318_Q01
G09
MCF 10A-H2B-mCherry Dasatinib
0.31623
18.98 27.76 21 941 0.0223 -0.0534
MN20160318_Q01
H12
MCF 10A-H2B-mCherry Dasatinib
0.31623
18.98 27.76 1038 941 1.1029 1.0389
MN20160318_Q01
H12
MCF 10A-H2B-mCherry Dasatinib
0.31623
18.98 27.76 1102 941 1.1709 1.0631
MN20160318_Q01
L08